menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Taking a Bite Out of Food Allergies: From Assessment Through Management

The prevalence of allergic diseases, including food allergies are increasing worldwide and the complexity and severity of allergic diseases continu...

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The prevalence of allergic diseases, including food allergies are increasing worldwide and the complexity and severity of allergic diseases continues to increase in children and young adults. At least 23 million people in the United States, including 7 million children, suffer from some kind of allergies – including specific food allergens.

    Join us as Dr. Wood discusses the quality of life burden of patients with food allergies as well as the individualized allergen avoidance strategies combined with appropriate medical intervention(s). Dr. Wood will also identify the hierarchy of causative allergens and discuss the effectiveness of a comprehensive avoidance and care plan for individuals impacted with food allergies.

  • Disclosure of Conflicts of Interest

     

    Faculty: 
    Robert A. Wood, MD 
    Professor of Pediatrics and International Health
    Director, Pediatric Allergy and Immunology 
    John Hopkins University School of Medicine
    Baltimore, Maryland

     

    Moderator: 
    Matt Birnholz, MD
    Medical Director
    ReachMD
    Chicago, IL

     

    Disclosure of Conflicts of Interest: 

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

     

    The following faculty have reported real or apparent conflicts of interest that have been resolved:

    • Dr. Birnholz has nothing to disclose.
    • Dr. Wood is a consultant for Sanofi and Stallergens and has conducted research for DBV Technologies.

     

    The following reviewers/planners/authors have reported real or apparent conflicts of interest that have been resolved:

    • Andy Beloff has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Sean T. Saunders, CHCP has nothing to disclose.
    • Emma DelVecchio has nothing to disclose. 
  • Target Audience

    The target audience for this activity includes Adult and Pediatric Primary Care Providers and Allergists.

  • Learning Objectives

    After listening to this activity, participants will be better able to:

    • Discuss the prevalence of food allergies in the US
    • Appreciate the medical, quality of life, and financial burdens associated with food allergies
    • Describe what the current best practices are in evaluating and recommending treatment for patients with suspected food allergies
    • Discuss the current testing available to identify and interpret the results of individuals with specific food allergens and have an understanding of current pharmacologic strategies to treat those results
  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be available for immediate download at www.reachmd.com.

  • Provider(s)/Educational Partner(s)

    Prova Education designs educational programs based on evidence-based medicine, needs and gaps analyses, learner feedback, and more. Its mission is to serve as an innovative and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

  • Commercial Support

    This activity is supported by an independent educational grant from Thermo Fisher Scientific.

  • Terms of Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither Prova Education nor TOPEC recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Prova Education or TOPEC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Instructions

    There are no fees for participating in and receiving CME credit for this activity. During the period October 1, 2015, through October 1, 2016, participants must 1) read the learning objectives and faculty disclosures; 2) listen to the full content of the activity and reflect upon its teachings; 3) successfully complete the post-test with a passing score and the evaluation at the end of the activity.

    Participants who successfully complete the activity, post-test and evaluation will have a statement of credit made available immediately.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ReachMD you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience."

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.